Daniel Masao Estandian completed a BA in Molecular and Cellular Biology at the University of California, Berkeley. His PhD in the MIT Brain and Cognitive Science program focused on developing new protein sequencing technologies. After graduating, Daniel spun out a company, Glyphic Biotechnologies to bring next-generation protein sequencing to the market.